anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Source Note

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 110,355
Current window 68,221-68,250
Pages 3,679
Rows per page 30
Component: Source Noteclear collectionreset all
18 30 60

Component

68,221-68,250 of 110,355

filter-aware
20
Includes a footnote regarding CECL transition and preliminary reporting status.Pathward Financial | Results Presentation Deck | 25 slides · Pathward Financial
Conference presentation Investor relations Beat · Evidence1 hit
22
Standard financial disclosure slide for non-GAAP metrics.Pathward Financial | Results Presentation Deck | 25 slides · Pathward Financial
Conference presentation Investor relations Beat · Appendix1 hit
23
The table shows the impact of excluding tax services on NCO ratios.Pathward Financial | Results Presentation Deck | 25 slides · Pathward Financial
Conference presentation Investor relations Beat · Appendix1 hit
25
The chart uses NAICS industry classifications. The bottom section provides a granular breakdown of product types for Manufacturing, Transportation & Warehousing, and Utilities.Pathward Financial | Results Presentation Deck | 25 slides · Pathward Financial
Conference presentation Investor relations Beat · Appendix1 hit
07
The chart uses a logarithmic scale on the y-axis to show the exponential decay of efficiency over time.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
08
The slide highlights the divergence between technological progress in computing and the stagnation in pharmaceutical R&D productivity.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
09
The slide uses a classic 'before-after' or 'gap' framing by contrasting two opposing trends to justify the company's existence.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
12
The slide uses a linear process flow to represent the drug discovery pipeline.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
15
The slide uses a funnel-style comparison for attrition rates, followed by two bar charts for cost and time.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
17
The chart uses a 2x2 matrix structure to map competitive positioning.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
37
The diagram uses a series of overlapping circles to represent stages of drug discovery, connected to specific technological capabilities (Phenomics, Transcriptomics, etc.) via vertical lines.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
49
The slide features a process flow diagram at the top right and a photo of the Biosero robotic system.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
56
The slide uses a before-after framing to contrast the current market reality with the desired therapeutic outcome.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
57
The slide outlines a drug discovery workflow from target identification to preclinical validation.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
58
The slide uses a 'problem-solution' structure, contrasting the high unmet need in cancer patients (left) with the efficacy of the REC-0648918 compound in mouse models (right).Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
59
The slide uses a 'problem-solution' structure, contrasting market statistics with experimental dot plots.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
60
The slide uses a problem-solution structure, contrasting market statistics with experimental cytokine data.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
61
The slide uses a problem-solution framing: the left side establishes the market problem (low efficacy/high toxicity), and the right side presents pre-clinical data as the solution.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
63
The slide highlights a specific subset of data (Compound 2A/2B) where phenomics shows a dramatic improvement, suggesting a redirection of chemistry efforts.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
68
The slide uses a decision tree/flowchart to segment patient populations by biomarker status and show corresponding mPFS outcomes.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
70
The slide uses two line charts to demonstrate efficacy. The top banner indicates the context is HR-proficient ovarian cancer PDX.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
85
The slide uses a table to contrast the prevalence of CCM with established orphan disease products.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
86
Includes a patient photo and source citations at the bottom.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
88
The slide is a scientific illustration of a cellular signaling pathway.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
89
The slide uses a bar chart to demonstrate that the intervention (Statin-Enhanced Diet) actually worsens the condition (higher lesion count) compared to the control (Standard Diet).Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
90
The slide uses a before-after visual comparison of microscopy images to frame the problem/opportunity for ML-based analysis.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
92
Slide 92 of a presentation deck.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
94
The table compares Placebo against 50mg, 200mg, 400mg, and 800mg doses across various safety metrics.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
95
The slide outlines a randomized controlled trial structure with three arms (400mg, 200mg, placebo) followed by a 12-month treatment period.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
97
Includes a patient photo and source citation.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit